Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex

Journal of Physiology and Pharmacology

Volumn 47, Issue 3, 1996, Pages 525-533

  Wedzony K ^a   Czyrak, A ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

c Fos immunoreactivity; CGP 40116; cingulate cortex; MK 801; NMDA antagonist; rats

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ANTAGONISM; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANTIBODIES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENES, FOS; GYRUS CINGULI; MALE; NEURONS; NUCLEAR PROTEINS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0029737072     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-1362.
2. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA, NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991; 254: 1515-1518.
3. Willetts J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 1990; 11: 423-428.
4. Mansbach RS, Geyer MA. Effect of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychipharmacology 1989; 2: 299-308.
5. Wȩdzony K, Gołembiowska K, Zazula M. Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn Schmiedebergs Arch Pharmacol 1994; 350: 555-562.
6. Robertson HA, Paul ML, Moratalla R, Graybiel AM. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can J Neural Sci 1991; 18: 380-383.
7. Criswell HE, Johnson KB, Müller RA Breese GR. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 1993; 265: 1001-1010.
8. Dragunow M, Faull RL. MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett 1990; 113: 144-150.
9. Gass P, Herdegen T, Bravo R, Kiessling M. Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-asparate receptor antagonists MK-801. Neuroscience 1993; 53: 749-758.
10. Hughes P, Dragunow M, Beilharz E, Lawlor P, Gluckman P. MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrococrtical neurones. Neuroreport 1993; 4: 183-186.
11. Deutch AY. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J Neural Transm Gen Sect 1993; 91: 197-221.
12. Wȩdzony K. Czyrak A. The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effect of MK-801. Brain Res 1994; 657: 351-356.
13. Wȩdzony K, Klimek V. Gołembiowska M. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res 1993; 622: 325-329.
14. Schmutz M, Portet C, Jeker A et al. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn Schmiedebergs Arch Pharmacol 1990; 342: 61-66.
15. Paxions G, Watson G. The rat brain in stereotaxic coordinates, 2nd edn., Academic Press, San Diego. 1986.
16. Sharp FR, Butman M, Koistinaho J et al. Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels. Neuroscience 1994; 62: 1079-1092.
17. Carter CJ. Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacology 1982; 21: 379-383.
18. Christie MJ, Bridge S, James LB, Beart PM. Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res 1985; 333: 169-172.
19. Christie MJ, James LB, Beart PM. An excitant amino acid projection from the medial prefrontal cortex to the anterior part of nucleus accumbens in the rat. J Neurochem 1985; 45: 477-482.
20. Pycock CJ, Kerwin RW, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 1980; 286: 74-76.
21. Olds ME. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation. Neuroscience 1990; 35: 313-325.
22. Tassin JP, Stinus L, Simon H et al. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res 1978; 141: 267-281.
23. Mitchell JB, Gratton A. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J Neurosci 1992; 12: 3609-3618.
24. Klockgether T, Turski L. NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neural 1990; 28: 539-546.
25. Morelli M, Fenu S, Pinna A, Di Chiara G. Opposite effects of NMDA receptor blockade on dopaminergic D1-and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 1992; 260: 402-408.